The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex

Zacks Dec 26 22:05

4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow

Zacks Dec 25 00:00

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

ADMA BiologicsDec 20 13:00

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

Zacks Dec 20 01:30

Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $28

Futu NewsDec 18 01:32 · Ratings

ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip?

Zacks Dec 11 01:30